Skip to main content

Doyle William F

In the past year, 1 open-market sale filing worth $933.1K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$933.1K
1 filing
Net
−$933.1K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Doyle William F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

NVCR NovoCure Ltd

Executive Chairman4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 5, 2026 (view filing)Mar 32 daysDoyle William FExecutive ChairmanSSale−71.9K$12.98−$933.1K−18.0%328.4K after2 lots
Aug 3, 2022 (view filing)Aug 21 dayDoyle William FExecutive ChairmanSSale−837$69.66−$58.3K−0.2%551.2K after
Mar 9, 2022 (view filing)Mar 81 dayDoyle William FExecutive ChairmanSSale−2.38K$70.10−$167.2K−0.4%552.0K after
Aug 4, 2021 (view filing)Aug 22 daysDoyle William FExecutive ChairmanSSale−995$149.38−$148.6K−0.2%554.4K after

ELAN Elanco Animal Health Inc

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 23, 2024 (view filing)May 212 daysDoyle William FDirectorPPurchase+15.0K$16.98+$254.7K+24.5%76.3K after
Mar 12, 2024 (view filing)Mar 84 daysDoyle William FDirectorPPurchase+15.0K$16.30+$244.5K+32.4%61.3K after